S100A10 and neoplasm: The results showed S100A10 AUG = 0.665 at 1 year of tumor progression (Fig. 4B), S100A10 AUG = 0.569 at 3 years of tumor progression (Fig. 4C), and S100A10 AUG = 0.615 at 5 years of tumor progression (Fig. 4D), S100A10 AUG = 0.879 at T1 and T2 stage (Fig. 4E), S100A10 AUG = 0.888 at T3 and T4 stage (Fig. 4F), S100A10 AUG = 0.868 at G1 and G2 stage (Fig. 4G), S100A10 AUG = 0.903 at G3 and G4 (Fig. 4H).